ATE382337T1 - Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer - Google Patents
Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymerInfo
- Publication number
- ATE382337T1 ATE382337T1 AT06008539T AT06008539T ATE382337T1 AT E382337 T1 ATE382337 T1 AT E382337T1 AT 06008539 T AT06008539 T AT 06008539T AT 06008539 T AT06008539 T AT 06008539T AT E382337 T1 ATE382337 T1 AT E382337T1
- Authority
- AT
- Austria
- Prior art keywords
- molecular weight
- less
- release
- fraction content
- base material
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 title abstract 3
- 229920001577 copolymer Polymers 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 1
- 238000005227 gel permeation chromatography Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005131893 | 2005-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382337T1 true ATE382337T1 (de) | 2008-01-15 |
Family
ID=36952555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06008539T ATE382337T1 (de) | 2005-04-28 | 2006-04-25 | Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7342048B2 (de) |
| EP (1) | EP1716847B1 (de) |
| AT (1) | ATE382337T1 (de) |
| DE (1) | DE602006000381T2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763769B2 (en) * | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
| CA2637569C (en) | 2006-01-18 | 2013-01-08 | Yuhua Li | Pharmaceutical compositions with enhanced stability |
| WO2012082765A2 (en) | 2010-12-16 | 2012-06-21 | The United State Of America. As Represented By The Secretary Department Of Health And Human Services | Methods for decreasing body weight and treating diabetes |
| CA2830600C (en) | 2011-03-23 | 2021-07-27 | Tomokazu AMANO | Compositions and methods for enhancing the pluripotency of stem cells |
| JP6129155B2 (ja) | 2011-04-12 | 2017-05-17 | ライジェル ファーマシューティカルズ, インコーポレイテッド | 同種移植片拒絶反応を抑制する方法 |
| WO2012158561A1 (en) | 2011-05-13 | 2012-11-22 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells |
| WO2013163176A1 (en) | 2012-04-23 | 2013-10-31 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| EP2968392B1 (de) | 2013-03-15 | 2020-08-05 | Elixirgen Therapeutics, Inc. | Verfahren zur verwendung von zscan4 zur verjüngung menschlicher zellen |
| CA2907915C (en) | 2013-04-03 | 2023-03-07 | Allertein Therapeutics, Llc | Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components |
| WO2015061361A1 (en) | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Mutated fibroblast growth factor (fgf) 1 and methods of use |
| EP3119415A4 (de) | 2014-03-07 | 2017-11-29 | The Arizona Board of Regents on behalf of the University of Arizona | Gegen natriumkanäle gerichtete nicht-narkotische crmp2-peptide für chronische schmerzen |
| WO2018160772A1 (en) | 2017-02-28 | 2018-09-07 | The United State Of America, As Represented By The Secretary, Department Of Health & Human Services | Method of treating obesity, insulin resistance, non-alcoholic fatty liver disease including non-alcoholic steatohepatitis |
| EP3775236A1 (de) | 2018-04-12 | 2021-02-17 | Krystal Biotech, LLC | Zusammensetzungen und verfahren zur behandlung von autosomaler rezessiver kongenitaler ichthyose |
| AU2019346549B2 (en) | 2018-09-24 | 2024-09-12 | Krystal Biotech, Inc. | Compositions and methods for the treatment of Netherton Syndrome |
| EP3856914A1 (de) | 2018-09-26 | 2021-08-04 | Krystal Biotech, Inc. | Zusammensetzungen und verfahren zur behandlung von hautkrankheiten |
| EP3860635A4 (de) | 2018-10-04 | 2022-07-06 | Rutgers, The State University of New Jersey | Verfahren zur verminderung der typ-2-zytokinvermittelten entzündung mit neuromedin-peptiden |
| CN113454105A (zh) | 2019-02-08 | 2021-09-28 | 克里斯托生物技术股份有限公司 | 用于递送cftr多肽的组合物和方法 |
| WO2020186187A1 (en) | 2019-03-13 | 2020-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for treating bladder and urethra dysfunction and disease |
| US20230118087A1 (en) | 2019-09-03 | 2023-04-20 | Krystal Biotech, Inc. | Compositions and methods for the treatment of congenital ichthyoses |
| CN110882222B (zh) * | 2019-12-05 | 2021-12-03 | 北京博恩特药业有限公司 | 颗粒组合物及制备方法和应用 |
| EP4077688A1 (de) | 2019-12-20 | 2022-10-26 | Krystal Biotech, Inc. | Zusammensetzungen und verfahren zur genabgabe an die atemwege und/oder lunge |
| CN111658620B (zh) * | 2020-04-30 | 2022-04-19 | 天津医科大学口腔医院 | 一种透明质酸-帕瑞昔布plga微球及其制备方法和应用 |
| WO2021225781A2 (en) | 2020-05-07 | 2021-11-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms |
| IL307350A (en) | 2021-04-02 | 2023-11-01 | Krystal Biotech Inc | Viral vectors for cancer treatment |
| JP2026508358A (ja) | 2023-03-02 | 2026-03-10 | クリスタル バイオテック インコーポレイテッド | がん治療用のインターロイキン-2およびインターロイキン-12 |
| EP4695408A1 (de) | 2023-04-13 | 2026-02-18 | Krystal Biotech, Inc. | Verfahren und zusammensetzungen zur behandlung von erkrankungen im zusammenhang mit dem auge |
| WO2026094007A1 (en) | 2024-11-01 | 2026-05-07 | Krystal Biotech, Inc. | Compositions and methods for the treatment of atpase disorders or diseases of the skin |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4328204A (en) * | 1977-03-02 | 1982-05-04 | Ethicon, Inc. | Absorbable polymer-drug compounds and method for making same |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| JPS60181029A (ja) | 1984-02-29 | 1985-09-14 | Toyo Jozo Co Ltd | 徐放性製剤の製法 |
| JP3168263B2 (ja) | 1984-07-06 | 2001-05-21 | 和光純薬工業株式会社 | 新規重合体及びこれを用いた医薬 |
| CA1256638A (en) * | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
| JPH0678425B2 (ja) | 1984-07-06 | 1994-10-05 | 和光純薬工業株式会社 | 重合体の新規製造法 |
| JP2551756B2 (ja) * | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
| GB8609537D0 (en) * | 1986-04-18 | 1986-05-21 | Ici Plc | Polyesters |
| JP2653255B2 (ja) | 1990-02-13 | 1997-09-17 | 武田薬品工業株式会社 | 長期徐放型マイクロカプセル |
| JP3254449B2 (ja) | 1990-04-13 | 2002-02-04 | 武田薬品工業株式会社 | 生体内分解型高分子重合物 |
| ATE168391T1 (de) * | 1990-04-13 | 1998-08-15 | Takeda Chemical Industries Ltd | Biologisch abbaubare hochmolekulare polymere, ihre herstellung und ihre verwendung |
| TW333456B (en) * | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| US5614390A (en) | 1996-06-14 | 1997-03-25 | Becton, Dickinson And Company | Species-specific detection of Mycobacterium kansasii |
| ES2221019T3 (es) * | 1996-10-31 | 2004-12-16 | Takeda Chemical Industries, Ltd. | Preparacion de liberacion mantenida. |
| NZ505651A (en) * | 1998-01-16 | 2003-08-29 | Takeda Chemical Industries Ltd | Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer |
| ES2256276T5 (es) * | 2000-08-07 | 2011-02-22 | Wako Pure Chemical Industries, Ltd. | Polímero de ácido láctico y procedimiento para su producción. |
| TWI225416B (en) * | 2001-06-29 | 2004-12-21 | Takeda Chemical Industries Ltd | Sustained-release composition and process for producing the same |
| JP2004155792A (ja) | 2001-06-29 | 2004-06-03 | Takeda Chem Ind Ltd | 徐放性組成物およびその製造法 |
| JP5188670B2 (ja) | 2001-06-29 | 2013-04-24 | 武田薬品工業株式会社 | 徐放性組成物およびその製造法 |
| JP3902518B2 (ja) | 2001-06-29 | 2007-04-11 | 武田薬品工業株式会社 | 徐放性組成物用乳酸−グリコール酸重合体の製造法 |
-
2006
- 2006-04-25 US US11/411,193 patent/US7342048B2/en not_active Expired - Lifetime
- 2006-04-25 AT AT06008539T patent/ATE382337T1/de active
- 2006-04-25 DE DE602006000381T patent/DE602006000381T2/de not_active Expired - Lifetime
- 2006-04-25 EP EP06008539A patent/EP1716847B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7342048B2 (en) | 2008-03-11 |
| DE602006000381D1 (de) | 2008-02-14 |
| US20060246139A1 (en) | 2006-11-02 |
| EP1716847B1 (de) | 2008-01-02 |
| EP1716847A1 (de) | 2006-11-02 |
| DE602006000381T2 (de) | 2008-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006000381D1 (de) | Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer | |
| BRPI0812064B8 (pt) | formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica | |
| WO2009132265A3 (en) | Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates | |
| NO20071853L (no) | Farmasoytisk sammensetning inneholdende en fast dispersjon med en polymermatriks inneholdende en jevn polydekstrosefase og en jevn fase av en polymer forskjellig fra polydekstrose. | |
| MX2007000009A (es) | Forma farmaceutica oral, protegida frente al abuso. | |
| WO2009129300A3 (en) | Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas | |
| WO2006017852A3 (en) | Pharmaceutical compositions for controlled release delivery of biologically active compounds | |
| CY1109606T1 (el) | Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο | |
| CY1117889T1 (el) | Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου | |
| CO5570662A2 (es) | Formulacion farmaceutica que contiene 3-(3-dimetilamino-1- etil-2-metil-propil) fenol y proporciona una liberacion retardada del ingrediente activo | |
| WO2010138544A3 (en) | Oral care formulations that enhance amount of soluble zinc | |
| WO2004026256A3 (en) | Sustained-release opioid formulations and methods of use | |
| MX336861B (es) | Formulacion de farmaco resistente al abuso. | |
| CY1115652T1 (el) | Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| EA200900246A1 (ru) | Подкожные имплантаты, высвобождающие активный компонент в течение продолжительного периода времени | |
| BRPI0511966A (pt) | composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons | |
| WO2006099514A3 (en) | Drug delivery compositions and related methods | |
| BR0212052A (pt) | Preparação de composição farmacêutica de liberação prolongada | |
| TN2009000476A1 (en) | Slow release pharmaceutical composition made of microparticles | |
| DE3872739D1 (de) | Arzneimittel mit langsamer freisetzung. | |
| PE20030066A1 (es) | Composicion de liberacion controlada y metodo para producirla | |
| BRPI0620185B8 (pt) | formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica | |
| BR0214159A (pt) | Sistema farmacêutico radiopaco de liberação prolongada | |
| GB0209749D0 (en) | Compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1716847 Country of ref document: EP |